Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
02/04/2026
The US S&P 500 e-mini futures fell by 1%, Nasdaq 100 futures fell by 1.3%, and Dow futures fell by 0.9%.
Latest
3 m ago
Solana DeFi protocol Drift was hacked, with losses estimated at around $270 million.
3 m ago
In the peak season, the glass prices hit a temporary new low.
3 m ago
Institution: Risk assets may face further selling before Easter.
4 m ago
Southbound funds today saw a significant net purchase of 19.828 billion yuan. In terms of the Stock Connect (Shanghai) program, Yingfu Fund and HSBC China Enterprises received net purchases of 6.768 billion Hong Kong dollars and 1.344 billion Hong Kong dollars respectively; China National Offshore Oil Corporation had the highest net selling amount of 1.366 billion Hong Kong dollars. In terms of the Stock Connect (Shenzhen) program, Yingfu Fund and HSBC China Enterprises received net purchases of 1.778 billion Hong Kong dollars and 1.25 billion Hong Kong dollars respectively; Alibaba-W had the highest net selling amount of 259 million Hong Kong dollars.
4 m ago
Yuekang Pharmaceutical: Subsidiary YKYY018 Inhalation Nebulizer for the Treatment and Prevention of Human Parainfluenza Virus Infection Indications Approved for Clinical Trials
See all latest